首页|Amsterdam University Medical Center Reports Findings in Artifi- cial Intelligence (Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancre- atic cancer)
Amsterdam University Medical Center Reports Findings in Artifi- cial Intelligence (Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancre- atic cancer)
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
2024 FEB 27 (NewsRx) – By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Artificial Intelligence is the subject of a report. According to news originating from Amsterdam, Netherlands, by NewsRx correspondents, research stated, “This study aimed to develop and evaluate an automatic model using artificial intelligence (AI) for quantifying vascular in- volvement and classifying tumor resectability stage in patients with pancreatic ductal adenocarcinoma (PDAC), primarily to support radiologists in referral centers. Resectability of PDAC is determined by the degree of vascular involvement on computed tomography scans (CTs), which is associated with considerable inter-observer variability.”
AmsterdamNetherlandsEuropeArtificial IntelligenceCancerEmerging TechnologiesGastroenterologyHealth and MedicineMachine LearningOncologyPancreasPancreatic CancerPancreatic Neoplasms